ID   T3HPD_HUMAN             Reviewed;         354 AA.
AC   Q96EM0; Q96LJ5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-APR-2021, entry version 123.
DE   RecName: Full=Trans-3-hydroxy-L-proline dehydratase {ECO:0000303|PubMed:22528483, ECO:0000303|PubMed:24649405};
DE            EC=4.2.1.77 {ECO:0000269|PubMed:22528483, ECO:0000269|PubMed:24649405};
DE   AltName: Full=Trans-L-3-hydroxyproline dehydratase;
GN   Name=L3HYPDH; Synonyms=C14orf149;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF THR-273.
RX   PubMed=22528483; DOI=10.1074/jbc.m112.363218;
RA   Visser W.F., Verhoeven-Duif N.M., de Koning T.J.;
RT   "Identification of a human trans-3-Hydroxy-L-proline dehydratase, the first
RT   characterized member of a novel family of proline racemase-like enzymes.";
RL   J. Biol. Chem. 287:21654-21662(2012).
RN   [6]
RP   CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=24649405; DOI=10.1016/j.fob.2014.02.010;
RA   Watanabe S., Tanimoto Y., Yamauchi S., Tozawa Y., Sawayama S., Watanabe Y.;
RT   "Identification and characterization of trans-3-hydroxy-L-proline
RT   dehydratase and Delta(1)-pyrroline-2-carboxylate reductase involved in
RT   trans-3-hydroxy-L-proline metabolism of bacteria.";
RL   FEBS Open Bio 4:240-250(2014).
CC   -!- FUNCTION: Catalyzes the dehydration of trans-3-hydroxy-L-proline to
CC       Delta(1)-pyrroline-2-carboxylate (Pyr2C). May be required to degrade
CC       trans-3-hydroxy-L-proline from the diet and originating from the
CC       degradation of proteins such as collagen-IV that contain it.
CC       {ECO:0000269|PubMed:22528483}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=trans-3-hydroxy-L-proline = 1-pyrroline-2-carboxylate + H2O;
CC         Xref=Rhea:RHEA:10320, ChEBI:CHEBI:15377, ChEBI:CHEBI:39785,
CC         ChEBI:CHEBI:57938; EC=4.2.1.77;
CC         Evidence={ECO:0000269|PubMed:22528483, ECO:0000269|PubMed:24649405};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.23 mM for trans-3-hydroxy-L-proline
CC         {ECO:0000269|PubMed:22528483};
CC         Vmax=39.5 umol/min/mg enzyme {ECO:0000269|PubMed:22528483};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:22528483};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:24649405}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:22528483}.
CC   -!- MISCELLANEOUS: In contrast to the T.cruzi proline racemase enzyme,
CC       lacks the conserved Cys at position 273 which is replaced by a Thr
CC       residue, transforming the racemase activity into dehydratase activity.
CC       {ECO:0000305|PubMed:22528483}.
CC   -!- SIMILARITY: Belongs to the proline racemase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK058165; BAB71696.1; -; mRNA.
DR   EMBL; AL159140; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012131; AAH12131.1; -; mRNA.
DR   CCDS; CCDS9739.1; -.
DR   RefSeq; NP_653182.1; NM_144581.1.
DR   SMR; Q96EM0; -.
DR   BioGRID; 125210; 24.
DR   IntAct; Q96EM0; 12.
DR   MINT; Q96EM0; -.
DR   STRING; 9606.ENSP00000247194; -.
DR   DrugBank; DB00172; Proline.
DR   iPTMnet; Q96EM0; -.
DR   PhosphoSitePlus; Q96EM0; -.
DR   BioMuta; L3HYPDH; -.
DR   DMDM; 296452868; -.
DR   EPD; Q96EM0; -.
DR   jPOST; Q96EM0; -.
DR   MassIVE; Q96EM0; -.
DR   MaxQB; Q96EM0; -.
DR   PaxDb; Q96EM0; -.
DR   PeptideAtlas; Q96EM0; -.
DR   PRIDE; Q96EM0; -.
DR   ProteomicsDB; 76425; -.
DR   Antibodypedia; 68443; 49 antibodies.
DR   Ensembl; ENST00000247194; ENSP00000247194; ENSG00000126790.
DR   GeneID; 112849; -.
DR   KEGG; hsa:112849; -.
DR   UCSC; uc001xee.2; human.
DR   CTD; 112849; -.
DR   DisGeNET; 112849; -.
DR   GeneCards; L3HYPDH; -.
DR   HGNC; HGNC:20488; L3HYPDH.
DR   HPA; ENSG00000126790; Low tissue specificity.
DR   MIM; 614811; gene.
DR   neXtProt; NX_Q96EM0; -.
DR   OpenTargets; ENSG00000126790; -.
DR   PharmGKB; PA134961537; -.
DR   VEuPathDB; HostDB:ENSG00000126790.11; -.
DR   eggNOG; ENOG502QRPF; Eukaryota.
DR   GeneTree; ENSGT00390000002032; -.
DR   HOGENOM; CLU_036729_0_1_1; -.
DR   InParanoid; Q96EM0; -.
DR   OMA; SHVLWTG; -.
DR   OrthoDB; 894373at2759; -.
DR   PhylomeDB; Q96EM0; -.
DR   TreeFam; TF329167; -.
DR   PathwayCommons; Q96EM0; -.
DR   BioGRID-ORCS; 112849; 6 hits in 995 CRISPR screens.
DR   ChiTaRS; L3HYPDH; human.
DR   GenomeRNAi; 112849; -.
DR   Pharos; Q96EM0; Tdark.
DR   PRO; PR:Q96EM0; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q96EM0; protein.
DR   Bgee; ENSG00000126790; Expressed in small intestine Peyer's patch and 195 other tissues.
DR   ExpressionAtlas; Q96EM0; baseline and differential.
DR   Genevisible; Q96EM0; HS.
DR   GO; GO:0016836; F:hydro-lyase activity; IDA:UniProtKB.
DR   GO; GO:0050346; F:trans-L-3-hydroxyproline dehydratase activity; IEA:UniProtKB-EC.
DR   InterPro; IPR008794; Pro_racemase_fam.
DR   PANTHER; PTHR33442; PTHR33442; 1.
DR   Pfam; PF05544; Pro_racemase; 1.
DR   PIRSF; PIRSF029792; Pro_racemase; 1.
DR   SFLD; SFLDS00028; Proline_Racemase; 1.
PE   1: Evidence at protein level;
KW   Lyase; Reference proteome.
FT   CHAIN           1..354
FT                   /note="Trans-3-hydroxy-L-proline dehydratase"
FT                   /id="PRO_0000288949"
FT   REGION          105..106
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   REGION          274..275
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        104
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         269
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   VARIANT         42
FT                   /note="V -> A (in dbSNP:rs17096291)"
FT                   /id="VAR_032540"
FT   VARIANT         125
FT                   /note="P -> S (in dbSNP:rs35622288)"
FT                   /id="VAR_062192"
FT   VARIANT         315
FT                   /note="A -> V (in dbSNP:rs1046701)"
FT                   /id="VAR_032541"
FT   VARIANT         341
FT                   /note="I -> V (in dbSNP:rs8660)"
FT                   /id="VAR_032542"
FT   MUTAGEN         273
FT                   /note="T->C: Regains racemase activity, catalyzing the
FT                   conversion of trans-3-hydroxy-L-proline to cis-3-hydroxy-D-
FT                   proline. Also catalyzes racemization of L-proline to D-
FT                   proline, albeit at a very low level. Has lost its original
FT                   dehydratase activity."
FT                   /evidence="ECO:0000269|PubMed:22528483"
FT   CONFLICT        9
FT                   /note="R -> W (in Ref. 3; AAH12131)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   354 AA;  38138 MW;  D279EE0B7C679969 CRC64;
     MESALAVPRL PPHDPGTPVL SVVDMHTGGE PLRIVLAGCP EVSGPTLLAK RRYMRQHLDH
     VRRRLMFEPR GHRDMYGAVL VPSELPDAHL GVLFLHNEGY SSMCGHAVLA LGRFALDFGL
     VPAPPAGTRE ARVNIHCPCG LVTAFVACED GRSHGPVRFH SVPAFVLATD LMVDVPGHGK
     VMVDIAYGGA FYAFVTAEKL GLDICSAKTR DLVDAASAVT EAVKAQFKIN HPDSEDLAFL
     YGTILTDGKD AYTKEPTTNI CVFADEQVDR SPTGSGVTAR IALQYHKGLL ELNQMRAFKS
     SATGSVFTGK AVREAKCGDF KAVIVEVSGQ AHYTGTASFI IEDDDPLRDG FLLK
//
